Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms.
Saved in:
| Title: | Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms. |
|---|---|
| Authors: | Malherbe JA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Fuller KA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Arshad A; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Nangalia J; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK., Romeo G; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia., Hall SL; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia., Meehan KS; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Guo B; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Howman R; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia., Erber WN; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia. |
| Source: | Journal of clinical pathology [J Clin Pathol] 2016 Feb; Vol. 69 (2), pp. 155-63. Date of Electronic Publication: 2015 Aug 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-4146 (Electronic) Linking ISSN: 00219746 NLM ISO Abbreviation: J Clin Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26290261 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Malherbe+JA%22">Malherbe JA</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Fuller+KA%22">Fuller KA</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Arshad+A%22">Arshad A</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Nangalia+J%22">Nangalia J</searchLink>; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Romeo+G%22">Romeo G</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Hall+SL%22">Hall SL</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Meehan+KS%22">Meehan KS</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Guo+B%22">Guo B</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Howman+R%22">Howman R</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Erber+WN%22">Erber WN</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220376601%22">Journal of clinical pathology</searchLink> [J Clin Pathol] 2016 Feb; Vol. 69 (2), pp. 155-63. <i>Date of Electronic Publication: </i>2015 Aug 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Pub%2E+Group%22">BMJ Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0376601 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1472-4146 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219746%22">00219746 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26290261 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jclinpath-2015-203177 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 155 Titles: – TitleFull: Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Malherbe JA – PersonEntity: Name: NameFull: Fuller KA – PersonEntity: Name: NameFull: Arshad A – PersonEntity: Name: NameFull: Nangalia J – PersonEntity: Name: NameFull: Romeo G – PersonEntity: Name: NameFull: Hall SL – PersonEntity: Name: NameFull: Meehan KS – PersonEntity: Name: NameFull: Guo B – PersonEntity: Name: NameFull: Howman R – PersonEntity: Name: NameFull: Erber WN IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2016 Feb Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1472-4146 Numbering: – Type: volume Value: 69 – Type: issue Value: 2 Titles: – TitleFull: Journal of clinical pathology Type: main |
| ResultId | 1 |